ALAMEDA, California – April 12, 2016 – AllCells, a leading provider of healthy & diseased hematological/immunological tissue, primary cell-based products, clinical grade products for further manufacturing of cell therapies, and bioservices will be attending the 2016 Biotechnology Industry Organization (BIO) International Convention One-on-One Partnering™ program to be held in San Francisco, CA, USA, 6-9 June 2016. Wayne Vaz – VP, Corporate & Business Development and Lewis Chapman – VP, Marketing & Sales will be available to meet at the Moscone Convention Center to discuss the company’s capabilities, strategic partnership and collaboration interests.
According to BIO, the BIO International Convention hosts 29,000+ 25 minute partnering meetings among 3,100+ companies in 3.5 days. Meetings are pre-scheduled before you arrive in San Francisco and hosted in the BIO Business Forum as well as Exhibitor Booths. BIO participants interested in learning more about AllCells or scheduling meetings to discuss partnering opportunities should login to BIO’s One-on-One Partnering™ program page. Individuals not directly participating in the Business Forum who wish to meet AllCells company representatives may contact Wayne Vaz or Lewis Chapman to make separate arrangements. BIO One-on-One Partnering is a trademark of the Biotechnology Industry Organization.
About AllCells, LLC. AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (“Bioservices”) custom designed according to customer criteria. For more information, please visit www.allcells.com.